Preventive Effect of the Herbal Preparation, HemoHIM, on Cisplatin-Induced Immune Suppression
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Seul-Ki | - |
dc.contributor.author | Kwon, Da-Ae | - |
dc.contributor.author | Lee, Hak Sung | - |
dc.contributor.author | Kim, Hyun Kyu | - |
dc.contributor.author | Kim, Won-Ki | - |
dc.date.accessioned | 2021-12-16T03:40:29Z | - |
dc.date.available | 2021-12-16T03:40:29Z | - |
dc.date.created | 2021-08-30 | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 1741-427X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/131715 | - |
dc.description.abstract | We determined the functional effect of the herbal preparation, HemoHIM, on the immune system, by examining the immunomodulatory activities of HemoHIM using immunocompromised mice. In this study, to examine the effect on the restoration of immune cells and balance in the immune system, we utilized a cisplatin-induced immunosuppression mouse model. Mice were injected int raperitoncally with cisplatin, an immunosuppressive anticancer, and then received oral doses of100, 250, and 500 mg/kg of HemoHIM for 14 days. The HemoHIM prevented the cisplatin-induced loss of body and organ weight. In terms of innate immunity, natural killer (NK) cell activity and phagocytosis increased in the HemoHIM group compared to the cisplatin control group. The HemoHIM group also showed a significantly higher expression of TM-mediated cytokines (interferon gamma (IFN-gamma), interleukin-2 (IL-2), and tumor necrosis factor alpha (TN F-alpha)) and inhibited the production of Th2-mediated cytokine interleukin-4 (IL-4) compared to cisplatin control group. These findings indicate that Hemol JIM enhances immune activity by modulating immune cell activity and cytokine secretion in immune-suppressed mice. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | HINDAWI LTD | - |
dc.title | Preventive Effect of the Herbal Preparation, HemoHIM, on Cisplatin-Induced Immune Suppression | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Won-Ki | - |
dc.identifier.doi | 10.1155/2019/3494806 | - |
dc.identifier.scopusid | 2-s2.0-85064005151 | - |
dc.identifier.wosid | 000463481500001 | - |
dc.identifier.bibliographicCitation | EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, v.2019 | - |
dc.relation.isPartOf | EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | - |
dc.citation.title | EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | - |
dc.citation.volume | 2019 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Integrative & Complementary Medicine | - |
dc.relation.journalWebOfScienceCategory | Integrative & Complementary Medicine | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.